Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide

  • Norbert W. Marschner, Matthias Adler, Gerd A. Nagel, Dietmar Christmann, Edgar Fenzl, Bahrat Upadhyaya
  • European Journal of Cancer and Clinical Oncology, September 1991, Elsevier
  • DOI: 10.1016/0277-5379(91)90311-z

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Norbert W Marschner